This is the authors' abstract. We don't add key points for this paper.
Cornell K strain chickens received a diet supplemented with 0, 0.1 and 1.0 ppm T3 from the day of hatching. At 28 days of age, splenocyte suspensions were prepared and analyzed by flow cytometry for interleukin-2 receptor (IL-2R) and CD3 expression. The low T3 dose increased the percentage of resting small cells expressing IL-2R while the mean fluorescence for this marker was enhanced only after mitogenic activation. This treatment did not alter the number of larger cells positive for IL-2R but did increase their mean fluorescence following mitogenic activation. The high T3 dose depressed the numbers of cells positive for IL-2R and their mean fluorescence amongst all splenocyte preparations. Both levels of T3 enhanced the numbers of CD3-positive cells in all cell preparations. These results suggest that the IL-2R expression can be modulated by in vivo T3 supplementation and that these correlate with the previously demonstrated changes in IL-2-like activity. The regulation of IL-2R expression provides one mechanism through which thyroid status may regulate immune function.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chandratilleke et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: